title: Trial design in the era of highly effective antiviral drug combinations for HIV infection.
authors.affiliation: Harvard School of Public Health, Department of Biostatistics, Boston, MA 02115, USA.
authors.forename: V
authors.initials: V
authors.lastname: DeGruttola
authors.forename: M
authors.initials: M
authors.lastname: Hughes
authors.forename: P
authors.initials: P
authors.lastname: Gilbert
authors.forename: A
authors.initials: A
authors.lastname: Phillips
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002985:Clinical Protocols; D004359:Drug Therapy, Combination; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D012367:RNA, Viral / Q000097:blood; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D012367:RNA, Viral